Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Gastroschisis and Autism-Dual Canaries in the Californian Coalmine.

Reece AS, Hulse GK.

JAMA Surg. 2019 Feb 6. doi: 10.1001/jamasurg.2018.4694. [Epub ahead of print] No abstract available.

PMID:
30725103
2.

Pathways from epigenomics and glycobiology towards novel biomarkers of addiction and its radical cure.

Reece AS, Wang W, Hulse GK.

Med Hypotheses. 2018 Jul;116:10-21. doi: 10.1016/j.mehy.2018.04.011. Epub 2018 Apr 12.

PMID:
29857889
3.
4.

Serum ionic dysequilibria in clinical opioid dependence: Cross-sectional and longitudinal studies.

Reece AS, Norman A, Hulse GK.

Hum Exp Toxicol. 2017 Aug;36(8):776-784. doi: 10.1177/0960327116666649. Epub 2017 Jan 1.

PMID:
28703074
5.

Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese.

Gao X, Wang Y, Lang M, Yuan L, Reece AS, Wang W.

OMICS. 2017 Jul;21(7):404-412. doi: 10.1089/omi.2017.0057.

PMID:
28692418
6.
7.
8.

Acceleration of cardiovascular-biological age by amphetamine exposure is a power function of chronological age.

Reece AS, Norman A, Hulse GK.

Heart Asia. 2017 Jan 10;9(1):30-38. doi: 10.1136/heartasia-2016-010832. eCollection 2017.

10.

Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal study.

Reece AS, Norman A, Hulse GK.

BMJ Open. 2016 Nov 7;6(11):e011891. doi: 10.1136/bmjopen-2016-011891.

11.

Medicinal cannabis in Australia: the missing links.

Reece AS, Hulse GK.

Med J Aust. 2016 Nov 7;205(9):425. No abstract available.

PMID:
27809740
12.

Dramatic acceleration of reproductive aging, contraction of biochemical fecundity and healthspan-lifespan implications of opioid-induced endocrinopathy-FSH/LH ratio and other interrelationships.

Reece AS, Thomas MR, Norman A, Hulse GK.

Reprod Toxicol. 2016 Dec;66:20-30. doi: 10.1016/j.reprotox.2016.09.006. Epub 2016 Sep 20.

PMID:
27663472
13.

Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity.

Reece AS, Hulse GK.

Mutat Res. 2016 Jul;789:15-25. doi: 10.1016/j.mrfmmm.2016.05.002. Epub 2016 May 4. Review.

PMID:
27208973
14.

Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System.

Hulse G, Kelty E, Hood S, Norman A, Basso MR, Reece AS.

Curr Pharm Des. 2015;21(23):3325-42. Review.

PMID:
26088116
15.
16.

Duration of opiate exposure as a determinant of arterial stiffness and vascular age in male opiate dependence: a longitudinal study.

Reece AS, Hulse GK.

J Clin Pharm Ther. 2014 Apr;39(2):158-67. doi: 10.1111/jcpt.12121. Epub 2013 Dec 16.

PMID:
24329809
17.

Lifetime opiate exposure as an independent and interactive cardiovascular risk factor in males: a cross-sectional clinical study.

Reece AS, Hulse GK.

Vasc Health Risk Manag. 2013;9:551-61. doi: 10.2147/VHRM.S48030. Epub 2013 Oct 2.

18.
19.

Elevated IGF1 in clinical opiate dependence.

Reece AS.

Neuro Endocrinol Lett. 2013;34(1):18-26.

PMID:
23524620
20.

Reduction in arterial stiffness and vascular age by naltrexone-induced interruption of opiate agonism: a cohort study.

Reece AS, Hulse GK.

BMJ Open. 2013 Mar 21;3(3). pii: e002610. doi: 10.1136/bmjopen-2013-002610.

21.

Impact of opioid pharmacotherapy on arterial stiffness and vascular ageing: cross-sectional and longitudinal studies.

Reece AS, Hulse GK.

Cardiovasc Toxicol. 2013 Sep;13(3):254-66. doi: 10.1007/s12012-013-9204-4.

PMID:
23456431
23.

Elevation of central arterial stiffness and vascular ageing in opiate withdrawal: cross-sectional and longitudinal studies.

Reece AS, Hulse GK.

Cardiovasc Toxicol. 2013 Mar;13(1):55-67. doi: 10.1007/s12012-012-9186-7.

PMID:
22991174
24.

Opiate-related testicular stem cell niche toxic pathology.

Reece AS.

Int J High Risk Behav Addict. 2012 Summer;1(2):86-7. doi: 10.5812/ijhrba.6522. Epub 2012 Jul 25. No abstract available.

25.

Restoring the double disconnect: towards a conceptual reinstatement of opiate addiction as a high risk behaviour.

Reece AS.

Int J High Risk Behav Addict. 2012 Summer;1(2):47-9. doi: 10.5812/ijhrba.6936. Epub 2012 Jul 25. No abstract available.

26.

Whats wrong with Medicare? Comment.

Reece AS.

Med J Aust. 2012 Feb 20;196(3):170. No abstract available.

PMID:
22451969
27.

Manifold implications of forgotten hyperglycemia in clinical opiate dependence.

Reece AS.

Drug Chem Toxicol. 2013 Jan;36(1):55-66. doi: 10.3109/01480545.2011.649286. Epub 2012 Feb 8.

PMID:
22313373
28.

High-sensitivity CRP in opiate addiction: relative and age-dependent elevations.

Reece AS.

Cardiovasc Toxicol. 2012 Jun;12(2):149-57. doi: 10.1007/s12012-012-9154-2.

PMID:
22297435
29.

Relative and age-dependent stimulation of soluble and cellular immunity in opiate dependence.

Reece AS.

J Addict Med. 2012 Mar;6(1):10-7. doi: 10.1097/ADM.0b013e31822c3bf4.

PMID:
21918466
30.

Differing age related trajectories of dysfunction in several organ systems in opiate dependence.

Reece AS.

Aging Clin Exp Res. 2012 Feb;24(1):85-96. doi: 10.3275/7518. Epub 2011 Feb 21.

PMID:
21339699
31.

Giant cystic lung disease with mediastinal compression in a short-term heavy cannabis smoker.

Reece AS.

BMJ Case Rep. 2011 Feb 2;2011. pii: bcr0420102934. doi: 10.1136/bcr.04.2010.2934. No abstract available.

32.

Hypothalamic opioid-melanocortin appetitive balance and addictive craving.

Reece AS.

Med Hypotheses. 2011 Jan;76(1):132-7. doi: 10.1016/j.mehy.2010.09.002.

PMID:
20926200
33.

Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing.

Reece AS.

Med Hypotheses. 2010 Dec;75(6):613-9. doi: 10.1016/j.mehy.2010.07.047. Epub 2010 Aug 25.

PMID:
20800362
34.

Favorable mortality profile of naltrexone implants for opiate addiction.

Reece AS.

J Addict Dis. 2010 Jan;29(1):30-50. doi: 10.1080/10550880903435988.

PMID:
20390697
35.

Clinical safety of 1500 mg oral naltrexone overdose.

Reece AS.

BMJ Case Rep. 2010 Sep 7;2010. pii: bcr0420102871. doi: 10.1136/bcr.04.2010.2871. Review.

36.

Diacetylmorphine versus methadone for opioid addiction.

Reece AS.

N Engl J Med. 2009 Nov 26;361(22):2194-5; author reply 2195. No abstract available.

PMID:
19950413
37.

Chronic toxicology of cannabis.

Reece AS.

Clin Toxicol (Phila). 2009 Jul;47(6):517-24. doi: 10.1080/15563650903074507. Review.

PMID:
19586351
38.

Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.

Reece AS.

J Subst Abuse Treat. 2009 Oct;37(3):256-65. doi: 10.1016/j.jsat.2009.03.008. Epub 2009 Apr 25.

PMID:
19394789
39.

Chronic ulcers caused by injection of substances: healing aided by naltrexone.

Reece AS.

Arch Dermatol. 2009 Apr;145(4):375-7. doi: 10.1001/archdermatol.2009.4. No abstract available.

PMID:
19380658
40.

Deterioration of indices of aortic augmentation and vascular age predate major cardiac events and interact with opiate dependence.

Reece AS.

Int J Cardiol. 2011 May 19;149(1):e8-11. doi: 10.1016/j.ijcard.2009.03.015. Epub 2009 Mar 26.

PMID:
19327850
41.

Severe multisystem dysfunction in a case of high level exposure to smoked cannabis.

Reece AS.

BMJ Case Rep. 2009;2009. pii: bcr08.2008.0798. doi: 10.1136/bcr.08.2008.0798. Epub 2009 Sep 2.

42.

Improved parameters of metabolic glycaemic and immune function and arterial stiffness with naltrexone implant therapy.

Reece AS.

BMJ Case Rep. 2009;2009:bcr0820080799. doi: 10.1136/bcr.08.2008.0799. Epub 2009 Apr 14.

43.

Appetitive and addictive factors pertinent to analysis of neuroscience studies of sexuality.

Reece AS.

Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):E86. doi: 10.1073/pnas.0807879105. Epub 2008 Nov 11. No abstract available.

44.

An intriguing association between dental and mental pathology in addicted and control subjects: a cross-sectional survey.

Reece AS.

Br Dent J. 2008 Dec 13;205(11):E22. doi: 10.1038/sj.bdj.2008.932. Epub 2008 Oct 24.

PMID:
18953330
45.

Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addiction.

Reece AS.

Addict Biol. 2009 Apr;14(2):214-26. doi: 10.1111/j.1369-1600.2008.00123.x. Epub 2008 Sep 22.

PMID:
18811680
46.

Cannabis and lung cancer.

Reece AS.

Eur Respir J. 2008 Jul;32(1):238-9. doi: 10.1183/09031936.00024408. No abstract available.

47.

Experience of road and other trauma by the opiate dependent patient: a survey report.

Reece AS.

Subst Abuse Treat Prev Policy. 2008 May 3;3:10. doi: 10.1186/1747-597X-3-10.

48.

Clinical implications of addiction related immunosuppression.

Reece AS.

J Infect. 2008 Jun;56(6):437-45. doi: 10.1016/j.jinf.2008.03.003. Epub 2008 Apr 28.

PMID:
18440646
49.

Cannabis as a cause of giant cystic lung disease.

Reece AS.

QJM. 2008 Jun;101(6):503. doi: 10.1093/qjmed/hcn040. Epub 2008 Mar 28. No abstract available.

PMID:
18375474

Supplemental Content

Loading ...
Support Center